Predicting Outcome in Cervix Carcinoma: a Prospective Study
NCT ID: NCT01825005
Last Updated: 2019-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
423 participants
OBSERVATIONAL
2013-02-28
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of the Results of Treatment for Cervical Carcinoma in Limburg
NCT01059695
Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients
NCT00788216
Study of a Predictor for Cervix Cancer
NCT01641484
Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)
NCT02428842
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
NCT01039493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1:surgery
treatment = surgery only
No interventions assigned to this group
group 2: radiotherapy
treatment = radiotherapy only
No interventions assigned to this group
group 3: RT and CT, and/or hyperthermia
treatment= radiotherapy combined with chemotherapy and/or hyperthermia
No interventions assigned to this group
group 4: stage IVb , any treatment
cervical cancer stage IV b, treatment = any systemic or radiation therapy and supportive care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent according to national rules
Exclusion Criteria
* no informed consent according to national rules
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht Radiation Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
P Lambin, Prof
Role: PRINCIPAL_INVESTIGATOR
Maastricht University hospital, dep of radiotherapy (Maastro clinic)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Hospital
Maastricht, , Netherlands
Bloemfontein medicross
Bloemfontein, Free State, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-4-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.